<DOC>
	<DOC>NCT02073084</DOC>
	<brief_summary>The purpose of this study is to determine the effects of K-877 on ECG parameters with a focus on cardiac repolarization compared with placebo in healthy adult subjects.</brief_summary>
	<brief_title>A Thorough Corrected QT Interval Trial</brief_title>
	<detailed_description />
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<criteria>Subject provides written informed consent before any study specific evaluation is performed. Subject is a healthy adult male or female volunteer, of any race and ethnicity, between the ages of 18 and 45 years, inclusive. Subject has a body mass index of 18 to 30 kg/m2, inclusive. Subject has clinically relevant abnormalities in the screening or check in assessments. Subject has a supine blood pressure after resting for at least 5 minutes that is higher than 140 mm Hg systolic or 90 mm Hg diastolic, or lower than 90 mm Hg systolic or 60 mm Hg diastolic. Subject has a supine Heart Rate (HR) (as measured at Screening or Checkin during collection of vital signs) after resting for at least 5 minutes that is outside the range of 40 to 90 beats per minute.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>